WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis
USA - NASDAQ:WAY - US9467841055 - Common Stock
39.33 USD
+0.36 (+0.92%)
39.33 USD
0 (0%)
WAY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. WAY has only an average score on both its financial health and profitability. WAY is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
WAY had positive earnings in the past year.
In the past year WAY had a positive cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.84%, WAY belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
WAY has a better Return On Equity (2.71%) than 88.57% of its industry peers.
WAY has a Return On Invested Capital of 3.67%. This is in the better half of the industry: WAY outperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for WAY is below the industry average of 6.80%.
The last Return On Invested Capital (3.67%) for WAY is above the 3 year average (2.09%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROIC | 3.67% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
1.3 Margins
WAY has a Profit Margin of 8.50%. This is amongst the best in the industry. WAY outperforms 94.29% of its industry peers.
WAY has a better Operating Margin (20.80%) than 94.29% of its industry peers.
WAY's Operating Margin has improved in the last couple of years.
The Gross Margin of WAY (67.32%) is better than 62.86% of its industry peers.
WAY's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% |
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
WAY has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WAY has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.38 indicates that WAY is not in any danger for bankruptcy at the moment.
WAY has a better Altman-Z score (3.38) than 71.43% of its industry peers.
WAY has a debt to FCF ratio of 4.45. This is a neutral value as WAY would need 4.45 years to pay back of all of its debts.
WAY has a Debt to FCF ratio (4.45) which is in line with its industry peers.
A Debt/Equity ratio of 0.39 indicates that WAY is not too dependend on debt financing.
WAY has a Debt to Equity ratio of 0.39. This is in the lower half of the industry: WAY underperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Altman-Z | 3.38 |
ROIC/WACC0.38
WACC9.62%
2.3 Liquidity
A Current Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
WAY has a better Current ratio (3.43) than 77.14% of its industry peers.
A Quick Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
WAY has a Quick ratio of 3.43. This is in the better half of the industry: WAY outperforms 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
WAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 199.63%, which is quite impressive.
WAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.14%.
Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 17.71% on average per year.
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
3.2 Future
The Earnings Per Share is expected to grow by 78.47% on average over the next years. This is a very strong growth
WAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.91% yearly.
EPS Next Y343.67%
EPS Next 2Y122.86%
EPS Next 3Y78.47%
EPS Next 5YN/A
Revenue Next Year12.33%
Revenue Next 2Y11.79%
Revenue Next 3Y11.91%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 35.43, WAY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.08, WAY is valued a bit more expensive.
With a Price/Forward Earnings ratio of 24.97, WAY is valued on the expensive side.
WAY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WAY is cheaper than 77.14% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.09. WAY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.43 | ||
| Fwd PE | 24.97 |
4.2 Price Multiples
WAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WAY is cheaper than 74.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, WAY is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.95 | ||
| EV/EBITDA | 22.08 |
4.3 Compensation for Growth
WAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WAY may justify a higher PE ratio.
WAY's earnings are expected to grow with 78.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y122.86%
EPS Next 3Y78.47%
5. Dividend
5.1 Amount
WAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
39.33
+0.36 (+0.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners69.9%
Inst Owner Change1.31%
Ins Owners1.26%
Ins Owner Change0.52%
Market Cap7.51B
Revenue(TTM)1.01B
Net Income(TTM)85.94M
Analysts86
Price Target50.64 (28.76%)
Short Float %6.03%
Short Ratio2.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.52%
Min EPS beat(2)-1.27%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)34.74%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)2.36%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.36%
Max Revenue beat(4)6.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.25%
PT rev (3m)3.06%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)6.43%
EPS NY rev (1m)0.19%
EPS NY rev (3m)4.66%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)1.24%
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)2.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.43 | ||
| Fwd PE | 24.97 | ||
| P/S | 7.42 | ||
| P/FCF | 26.95 | ||
| P/OCF | 24.65 | ||
| P/B | 2.37 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.08 |
EPS(TTM)1.11
EY2.82%
EPS(NY)1.58
Fwd EY4%
FCF(TTM)1.46
FCFY3.71%
OCF(TTM)1.6
OCFY4.06%
SpS5.3
BVpS16.62
TBVpS-4.35
PEG (NY)0.1
PEG (5Y)N/A
Graham Number20.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROCE | 4.65% | ||
| ROIC | 3.67% | ||
| ROICexc | 3.97% | ||
| ROICexgc | 91.57% | ||
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% | ||
| FCFM | 27.55% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexgc growth 3Y7.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 15.78% | ||
| Cap/Sales | 2.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.15% | ||
| Profit Quality | 324.12% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 3.38 |
F-Score8
WACC9.62%
ROIC/WACC0.38
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y343.67%
EPS Next 2Y122.86%
EPS Next 3Y78.47%
EPS Next 5YN/A
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
Revenue Next Year12.33%
Revenue Next 2Y11.79%
Revenue Next 3Y11.91%
Revenue Next 5YN/A
EBIT growth 1Y85.59%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.75%
EBIT Next 3Y42.44%
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A
WAYSTAR HOLDING CORP / WAY FAQ
What is the fundamental rating for WAY stock?
ChartMill assigns a fundamental rating of 5 / 10 to WAY.
What is the valuation status for WAY stock?
ChartMill assigns a valuation rating of 5 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.
Can you provide the profitability details for WAYSTAR HOLDING CORP?
WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.
What is the financial health of WAYSTAR HOLDING CORP (WAY) stock?
The financial health rating of WAYSTAR HOLDING CORP (WAY) is 6 / 10.